Research Article
Endothelial Dysfunction of Patients with Peripheral Arterial Disease Measured by Peripheral Arterial Tonometry
Table 1
Patients characteristics.
| Variables | Subjects () |
| Age (years) | 73.6 8.1 | Gender (male/female) | 50/17 | Body mass index (kg/m2) | 22.4 2.5 | Comorbidities | | Smoking history | 51 (76.1%) | Hypertension | 56 (83.6%) | Dyslipidemia | 38 (56.7%) | Coronary artery disease | 19 (28.4%) | Cerebrovascular disease | 10 (14.9%) | Chronic kidney disease | 16 (23.9%) | Diabetes mellitus | 38 (56.7%) | Medications | | Nitroglycerin | 2 (3.0%) | -Blocker | 13 (19.4%) | ACE-I | 7 (10.4%) | ARB | 37 (55.2%) | Statin | 32 (47.8%) | Hemodynamical parameters | | Ankle brachial pressure index | 0.85 0.18 | Reactive hyperemia index | 1.61 0.51 | Laboratory findings | | White blood cell (/μL) | 6605 1558 | Hemoglobin (g/dL) | 13.5 1.9 | Platelet (104/μL) | 22.6 4.9 | Prothrombin time (%) | 99.6 14.8 | Activated partial thromboplastin time (sec) | 29.7 3.8 | Fibrinogen (mg/dL) | 323.1 63.1 | Albumin (g/dL) | 4.02 0.39 | Creatinine (mg/dL) | 1.07 0.54 | Total cholesterol (mg/dL) | 191.9 39.8 | Triglycerides (mg/dL) | 135.1 123.2 | High-density lipoprotein (mg/dL) | 62.5 22.6 | Low-density lipoprotein (mg/dL) | 110.2 24.8 | Hemoglobin A1c (%) | 6.38 0.74 | C-reactive protein (mg/dL) | 0.27 0.48 |
|
|
ACE-I, angiotensin converting enzyme-inhibitor; ARB, angiotensin II receptor blocker.
|